EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bi-Allelic MARVELD2 Variant Identified with Exome Sequencing in a Consanguineous Multiplex Ghanaian Family Segregating Non-Syndromic Hearing Loss

Elvis Twumasi Aboagye iD, Samuel Mawuli Adadey iD, Leonardo Alves de Souza Rios iD, Kevin K Esoh, Edmond Wonkam-Tingang iD, Lettilia Xhakaza iD, Carmen De Kock iD, Isabelle Schrauwen iD, Lucas Amenga-Etego iD, Dirk Lang iD, Gordon A Awandare, Suzanne M Leal und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Elvis Twumasi Aboagye und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa. Hauptthemen laut MEDLINE: Hearing Loss, Membrane Proteins. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic studies and phenotypic expansion of hearing loss (HL) for people living in Africa are greatly needed. We evaluated the clinical phenotypes of three affected siblings presenting non-syndromic (NS) HL and five unaffected members of a consanguineous Ghanaian family. Analysis of exome sequence data was performed for all affected and one unaffected family members. In-depth genetic and cellular characterization studies were performed to investigate biological significance of the implicated variant using bioinformatic tools and cell-based experimentation. Audiological examinations showed severe-to-profound, bilateral, symmetrical, and post-lingual onset. The whole-exome sequencing (WES) identified a homozygous frameshift variant: MARVEL domain containing 2 (MARVELD2):c.1058dup;p.(Val354Serfs*5) in all affected siblings. This frameshift variant leads to an early stop codon insertion and predicted to be targeted by nonsense medicated decay (mutant protein predicted to lack conserved C-terminal domain if translated). Cell immunofluorescence and immunocytochemistry studies exposed the functional impact of the mutant protein’s expression, stability, localization, protein–protein binding, barrier function, and actin cytoskeleton architecture. The identified variant segregates with NSHL in the index Ghanaian family. The data support this nonsense variant as pathogenic, likely to impact the homeostasis of ions, solutes, and other molecules, compromising membrane barrier and signaling in the inner ear spaces.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hearing LossMembrane ProteinsHumansExome SequencingGhanaMalePedigreeFemaleConsanguinityFrameshift MutationAdultAllelesPhenotypeChild

Stichwörter der Autor:innen

AfricaGhanaMARVELD2consanguinitynon-syndromic hearing losswhole-exome sequencing

Substanzen

Membrane Proteins

Autor:innen und Institutionen

  • Department of Pathology, Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
  • West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Legon, Accra LG 54, Ghana.
  • Department of Pathology, Division of Haematology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
  • McKusick-Nathans Institute & Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Department of Translational Neurosciences, University of Arizona College of Medicine Phoenix, Phoenix, AZ 85004, USA.
  • Department of Human Biology, Division of Cell Biology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.

ORCID-Profile: Elvis Twumasi Aboagye, Samuel Mawuli Adadey, Leonardo Alves de Souza Rios, Edmond Wonkam-Tingang, Lettilia Xhakaza, Carmen De Kock, Isabelle Schrauwen, Lucas Amenga-Etego, Dirk Lang, Shaheen Mowla, Ambroise Wonkam

Förderung

  • NIDCD NIH HHS
  • NIH HHS
  • NHGRI NIH HHS
  • World Bank African Centre of Excellence PhD fellowship
  • Wellcome Trust
  • Wellcome Trust and African Academy of Sciences
  • National Institutes of Health (NIH)
  • African Academy of Science/Wellcome Trust

Zitieren

APA

Twumasi Aboagye, E., Adadey, S. M., Alves de Souza Rios, L., Esoh, K. K., Wonkam-Tingang, E., Xhakaza, L., De Kock, C., Schrauwen, I., Amenga-Etego, L., Lang, D., Awandare, G. A., Leal, S. M., Mowla, S., & Wonkam, A. (2025). Bi-Allelic MARVELD2 Variant Identified with Exome Sequencing in a Consanguineous Multiplex Ghanaian Family Segregating Non-Syndromic Hearing Loss. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073337

Vancouver

Twumasi Aboagye E, Adadey SM, Alves de Souza Rios L, Esoh KK, Wonkam-Tingang E, Xhakaza L, et al. Bi-Allelic MARVELD2 Variant Identified with Exome Sequencing in a Consanguineous Multiplex Ghanaian Family Segregating Non-Syndromic Hearing Loss. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073337

BibTeX
@article{TwumasiAboagye2025,
  author = {Twumasi Aboagye, Elvis and Adadey, Samuel Mawuli and Alves de Souza Rios, Leonardo and Esoh, Kevin K and Wonkam-Tingang, Edmond and Xhakaza, Lettilia and De Kock, Carmen and Schrauwen, Isabelle and Amenga-Etego, Lucas and Lang, Dirk and Awandare, Gordon A and Leal, Suzanne M and Mowla, Shaheen and Wonkam, Ambroise},
  title = {Bi-Allelic MARVELD2 Variant Identified with Exome Sequencing in a Consanguineous Multiplex Ghanaian Family Segregating Non-Syndromic Hearing Loss},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073337}
}
Kostenlos starten →